ArticleBlood2021

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.

Eytan M Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.